Posts tagged as:


Behind XBI’s 2014 Tear

by on February 4, 2014

As we close out the first month of the year, 2014 is looking a lot less rosy than its predecessor. After last year brought on an insatiable bull run, it seems that markets were apprehensive to make a move higher. The last few sessions of January saw a harsh sell-off in a number of securities, with many starting the year in the red. There is one ETF, however, that has outdone many of its peers by a sizable margin, the SPDR S&P Biotech ETF (XBI). In fact, XBI is the best performing biotech ETF of the year, leaving many scratching their heads as to what lifted this ETF to such highs [for more ETF news and analysis subscribe to our free newsletter]. [click to continue…]

{ Comments on this entry are closed }